NoticeInformation only. Not medical advice. Nothing here is a recommendation to use any substance. Read full disclaimer
25 items
FDA press releases
The FDA announced accelerated approval of Voceryq for adults with recurrent respiratory papillomatosis. The agency describes it as the first plasmid DNA-based immunotherapy approved for this condition.
POLITICO Pro
POLITICO Pro’s headline identifies states as the next hurdle for RFK Jr.’s peptide push. The provided excerpt repeats the headline and is too thin to summarize the policy details or state-level issues.
RNZ
The provided text is too thin to summarize beyond the headline. RNZ’s headline says peptide users cite affordability and easy access as reasons for injecting unregulated drugs, but the excerpt provides no further details.
USA Today
USA Today’s headline reports that US Health Secretary RFK Jr. opened access to some unapproved peptides. The excerpt only repeats the headline and is too thin to summarize the action or identify the peptides involved.
SSBCrack
The SSBCrack headline says an HHS plan for peptide drug access faces FDA opposition amid safety concerns. The excerpt only repeats the headline and is too thin to summarize the plan, opposition, or safety concerns in detail.
FDA press releases
The FDA announced the launch of the Neuroscience Advancement and Innovation Nexus (NAIN), a program to advance neuroscience medical product development. The agency describes it as aligned with the Trump Administration’s efforts to accelerate medical innovation; the excerpt is too thin to summarize program details or peptide implications.
FDA press releases
According to the FDA excerpt, the agency approved Hibsago (bepirovirsen) injection for chronic hepatitis B infection in certain adults without cirrhosis. The approval is for treatment in combination with existing antiviral therapy.
FDA press releases
The FDA approved the first generic version of Climara Pro, an estradiol and levonorgestrel transdermal hormone therapy patch. The approval covers a patch for women with an intact uterus.
FDA press releases
The FDA released final guidance on how drug companies can develop, distribute, and label apps used alongside prescription medicines. The excerpt does not identify any peptide medicines or provide details of the guidance.
FDA press releases
The FDA granted accelerated approval for a new use of Jemperli (dostarlimab-gxly) in certain patients with locally advanced rectal cancer. The agency says the immunotherapy may allow some patients to avoid chemotherapy, radiation and surgery.
FDA press releases
The FDA announced the Rare Disease Framework Initiative to reimagine drug and biologic development for rare diseases. The excerpt is too thin to summarize beyond that announcement and provides no peptide-specific details.
FDA press releases
The FDA announced approval of a first treatment for certain people with BCG-unresponsive bladder cancer. The provided text repeats only the headline and is too thin to summarize the treatment, evidence, or any peptide connection.
FDA press releases
The FDA announced a request for information on approaches it is considering for designing early-phase clinical trials of ibogaine drug products. The agency is seeking public input on those approaches.
FDA press releases
The FDA approved the Autus Size-Adjustable Valve, a surgically implanted pulmonary heart valve for children with congenital pulmonary valve disease. The announcement describes it as the first heart valve designed to grow with children.
FDA press releases
The FDA announced a nationwide recruitment effort to broaden scientific expertise and consumer perspectives on its advisory committees. These independent bodies inform public health decisions; the excerpt provides no peptide-specific information.
FDA press releases
The Justice Department announced federal charges against Indian nationals Swapnadip Roy, 33, and Vicky Ramancha, 37. The FDA release’s title links the charges to an investigation into transnational counterfeit drug distribution, but the excerpt is too thin to establish details or any peptide connection.
FDA press releases
The FDA announced approval of Emcitate (tiratricol) for peripheral thyrotoxicosis, identifying it in the headline as the first treatment for MCT8 deficiency. The excerpt is truncated and provides too little detail to summarize the eligible population or supporting evidence.
FDA press releases
FDA says it intends to evaluate changes to the Premarket Tobacco Product Application (PMTA) regulatory framework. The agency is reviewing its implementation experience and recent judicial developments, including a federal lawsuit in the Northern District of Texas challenging the current framework.
FDA press releases
According to the FDA, a federal court entered a consent decree against Gold Star Distribution, Inc. following persistent insanitary warehouse conditions. The Sept. 21, 2026 order stops distribution of FDA-regulated products until the company brings its operations into compliance with federal requirements.
FDA press releases
The FDA issued a direct final rule clarifying that non-animal methods can be used, where appropriate, to test the safety of drugs and biological products. The update concerns testing before these products are tried in humans.